Other Events ·
Nasdaq confirms POMDOCTOR regained compliance with the $1.00 minimum bid price requirement
POMPOMDOCTOR Ltd
On November 5, 2026, Nasdaq notified POMDOCTOR that it has regained compliance with the minimum bid price requirement of $1.00 per share under Listing Rule 5450(a)(1). Consequently, a hearing before the Nasdaq Hearings Panel scheduled for November 12, 2026, was cancelled. The company's Class A ordinary shares will continue to be listed and traded on the Nasdaq Global Market under the ticker symbol "POM." This compliance resolves a delisting determination issued by Nasdaq staff on October 6, 2026, following 30 consecutive days of closing bid prices below $1.00. POMDOCTOR is a digital healthcare company focused on advancing AI-enabled healthcare solutions and expanding predictive healthcare capabilities.